vimarsana.com

Page 5 - அலையன்ஸ் ஆபத்து காற்றழுத்தமானி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Allianz Risk Barometer: COVID-19 Trio Tops Global Business Risks

Getty Images Business interruption, pandemic outbreak and cyber incidents rank as the Top 3 business risks of 2020, going into 2021, according to the Allianz Risk Barometer 2021. “The Allianz Risk Barometer 2021 is clearly dominated by the COVID-19 trio of risks. Business interruption, pandemic and cyber are strongly interlinked, demonstrating the growing vulnerabilities of our highly globalized and connected world,” says Joachim Müller, CEO of Allianz. “The Coronavirus pandemic is a reminder that risk management and business continuity management need to further evolve in order to help businesses prepare for, and survive, extreme events. While the pandemic continues to have a firm grip on countries around the world, we also have to ready ourselves for more frequent extreme scenarios, such as a global-scale cloud outage or cyberattack, natural disasters driven by climate change or even another disease outbreak.”

Allianz Risk Barometer 2021: Pandemic outbreak overtakes Business Interruption as top business risk in China

Allianz Risk Barometer 2021: Pandemic outbreak overtakes Business Interruption as top business risk in China
livenews.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from livenews.co.nz Daily Mail and Mail on Sunday newspapers.

Tobias Nanda to Lead Brands Team

Tobias Nanda to Lead Brands Team Tobias Nanda to Lead Brands Team Boston, Jan. 25, 2021 Gordon Brothers, the global advisory, restructuring and investment firm, has named Tobias Nanda as President of Brands. Based in Boston, Nanda is responsible for developing and executing Gordon Brothers’ brand investment strategies through acquisition and lending in all global markets. He has nearly 20 years of experience leading deals, serving on boards of directors and actively working with management teams in private equity to develop and implement their corporate growth strategies. Prior to leading Gordon Brothers’ brand investment strategies, Nanda held senior positions at several private equity firms and was Vice President of GB Merchant Partners at Gordon Brothers. He is a former board director of global brands and branded retailers in the U.S., U.K. and EU.

Freddie Mac Multifamily 2021 Outlook Projects Rebound in Origination Volume Boosted by Smaller Markets

Freddie Mac Multifamily 2021 Outlook Projects Rebound in Origination Volume Boosted by Smaller Markets Freddie Mac Multifamily 2021 Outlook Projects Rebound in Origination Volume Boosted by Smaller Markets MCLEAN, Va., Jan. 25, 2021 Freddie Mac (OTCQB: FMCC) projects that overall multifamily origination volume will rebound in 2021, growing to $340 billion by year-end as the economy is boosted by another federal stimulus package. The recovery is supported in part by growth in smaller metropolitan markets, like Phoenix and Tampa, with larger cities expected to recovery more gradually. The overall market is bolstered by sustained demand for multifamily properties as investors take the long-view of rents and vacancies, which although temporarily impacted by the pandemic are expected to rebound in a move toward reestablishing the trends of the past decade, according to the report.

Leading Microbiome Researcher Dr Eric Pamer Joins Diversigen s Scientific Advisory Board

Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board ST. PAUL, Minn., Jan. 25, 2021 Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ: OSUR), today announced that Eric Pamer, M.D., Professor of Medicine, Section of Infectious Diseases and Global Health and director of the Duchossois Family Institute at the University of Chicago, has joined its scientific advisory board. Dr. Pamer is an internationally recognized physician and scientist in the microbiome field. His research focuses on the role of the microbiome in immune defense and disease resistance.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.